1. pH-dependent ileocolonic drug delivery, part I: in vitro and clinical evaluation of novel systems

   Broesder, A., Woerdenbag, H. J., Prins, G. H., Nguyen, D. N., Frijlink, H. W. & Hinrichs, W. L. J., Aug-2020, In : Drug Discovery Today. 25, 8, p. 1362-1373 12 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

2. pH-dependent ileocolonic drug delivery, part II: Preclinical evaluation of novel drugs and novel excipients

   Broesder, A., Kosta, A-M. M. A. C., Woerdenbag, H. J., Nguyen, D. N., Frijlink, H. W. & Hinrichs, W. L. J., Aug-2020, In : Drug Discovery Today. 25, 8, p. 1374-1388 15 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

3. Cysteamine: an old drug with new potential

   Besouw, M., Masereeuw, R., van den Heuvel, L. & Levtchenko, E., Aug-2013, In : Drug Discovery Today. 18, 15-16, p. 785-792 8 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

4. CRISPR/Cas9: A powerful tool for identification of new targets for cancer treatment

   Liu, B., Saber, A. & Haisma, H. J., Apr-2019, In : Drug Discovery Today. 24, 4, p. 955-970

   Research output: Contribution to journal › Review article › Academic › peer-review

5. When More Isn’t Merrier: Pharmaceutical Alliance Networks and Breakthrough Innovation

   Dong, J. Q. & McCarthy, K. J., Mar-2019, In : Drug Discovery Today. 24, 3, p. 673-677 5 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (21) »